SOURCE: Healtheuniverse, Inc.

March 06, 2007 07:37 ET

Healtheuniverse Research and Development Center Singapore to Advance Adult Stem Cell Applications and Therapies

Adult Stem Cell R & D Center Moving Forward With Alliance and Support From the Economic Development Board of Singapore

COVINA, CA -- (MARKET WIRE) -- March 6, 2007 -- Healtheuniverse, Inc. (PINKSHEETS: HLUN), a biotechnology development firm engaged in research, development and commercialization of regenerative medicine therapies utilizing non-embryonic adult stem cells, announced today that it is completing its infrastructure development in Singapore for its adult stem cell research and development center. The wholly owned subsidiary, Healtheuniverse Ptd Ltd., will collaborate with other research and development facilities in Asia in preparation for clinical trials. Expansion of pre-clinical and clinical capabilities in Singapore is a cornerstone in the Company's development of the first commercial stem cell therapy in the $15 billion worldwide plastic, reconstructive and cosmetic surgery market.

Healtheuniverse Pte Ltd., under the direction of the Company's Chief Executive Officer and Plastic and Reconstructive Surgeon Dr. Vipul Dev M.D., is developing the adult stem cell R & D center with an alliance and support from the Economic Development Board of Singapore (EDB). The Economic Development Board (EDB) is Singapore's lead agency responsible for planning and executing strategies to sustain Singapore's position as a compelling global hub for business and investment.


HEALTHeUNIVERSE Inc. is engaged in research, development and commercialization of regenerative medicine therapies utilizing non-embryonic adult stem cells for use in plastic and reconstructive surgery, orthopedic surgery, vascular surgery, cardiac surgery, and wound care. Healtheuniverse strives to be the first to commercialize the use of regenerative medicine in plastic and reconstructive surgery and to develop therapeutic uses in disease related commercial applications. More information on Healtheuniverse is available online at

Safe Harbor Statement

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Healtheuniverse Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

Contact Information

  • For more information, please contact:
    Healtheuniverse, Inc.
    Investor Relations
    Email Contact